| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +1.24K | 9.4% | $16.56 | +$20.5K |
| Sells | 1 | -12K | 90.6% | $20.76 | -$249K |
| Net | 0 | -10.8K | -81.3% | -$229K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | Director | $26.2M | Aug 10, 2021 | ||
| Pad Chivukula | Chief Scientific Officer & COO | $9.04M | -$249K | -2.68% | Dec 16, 2024 |
| Andy Sassine | Chief Financial Officer, Director | $3.67M | +$20.5K | +0.56% | Aug 15, 2025 |
| Peter C. Farrell | Director | $3.16M | Jun 9, 2025 | ||
| Magda Marquet | Director | $899K | Jun 9, 2025 | ||
| James F. Barlow | Director | $421K | Jun 9, 2025 | ||
| John Markels | Director | $100K | Jun 9, 2025 | ||
| Edward W. Holmes | Director | $100K | Jun 9, 2025 | ||
| Jing L. Marantz | Director | $100K | Jun 9, 2025 | ||
| Keith C. Kummerfeld | Senior Vice President of Finance (Principal Accounting Officer) | $17.8K | Dec 15, 2023 | ||
| Joseph E. Payne | President and CEO, Director | Dec 16, 2024 | |||
| Karah Parschauer | Director | Jun 18, 2021 | |||
| Moncef Slaoui | Director | Jun 9, 2025 | |||
| Lance Kurata | Chief Legal Officer | Dec 16, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|